Helping decision-makers, program managers, and funding partners achieve maximum impact with the funding available for the HIV response and plan for sustainability.

Optima HIV

To download a copy of our HIV brochure, click here.

To view our peer-reviewed publication that describes the Optima HIV model, please click here .

Optima HIV helps to:

  • Identify HIV programs to be prioritized with available funding
  • Determine resources required to reach HIV coverage targets and epidemiological objectives
  • Establish the most cost-effective mix of HIV interventions to respond to a country's HIV epidemic
  • Reveal the investment allocation and coverage allocation for minimizing HIV incidence, HIV-related mortality, or both
  • Calculate future treatment, care, and support costs for people affected by HIV or AIDS
  • Estimate the number of new HIV infections and HIV-related deaths averted through existing or optimized investment

Precursors to the Optima HIV model were created in 2004, and has continued to evolve in sophistication, relevance and use. The Optima HIV brand was launched in 2012. Since then it has been applied in over 40 countries worldwide. Findings from Optima HIV applications and studies have been used to inform the United Nations General Assembly, Global Fund to Fight AIDS, Tuberculosis and Malaria, Association of Southeast Asian Nations, national HIV/AIDS Strategic Plans, national Global Fund Concept Note applications, and country reports. Optima HIV results can be used to improve country and health policy decision-making by informing domestic and donor public health funding allocations towards better achieving HIV targets.

The Optima HIV software was conceptualised and developed by the Optima Consortium for Decision Science with technical input from the World Bank, and is owned by Optima Consortium for Decision Science, Ltd.